|
From the Director
We are on our summer schedule, so this is the only newsletter we'll send in the month of July, unless there's breaking news. Our home base in Maine is beautiful- hope you get to enjoy the summer somewhere nice as well!
Here are some recent articles we think are interesting. We also post regularly on our Facebook page and our website, so check them out. Also, our office is still fielding calls all summer long regardless of vacation schedules, so give us a call if there's breaking news of interest or you want help or information on state policy.
Massachusetts gift ban. The best news of the month is that Massachusetts has NOT repealed its groundbreaking pharma gift ban. It also has kept the Bay State-only ban on retail coupons for pharmaceuticals and continued some funding for academic detailing. Read more
Iowa drug depository. Iowa has pioneered a program that receives unused prescription drugs, mostly from long term care facilities, and redistributes them through a unique non-profit, state-assisted pharmacy. Learn more
PBM issues in the states. Consumers in Texas and Maine were on the losing end of of the votes on bills regarding pharmacy benefit managers. Maine's new GOP-led legislature and Governor succeeded in repealing the state's pathbreaking PBM transparency and anti-fraud law, and Texas lawmakers lost their battle to prevent PBMs that engage in acts of fraud from contracting with the state's Medicaid managed care program. Read more Interested in the impact of marketing to kids? Maine was shot down when it tried to regulate predatory marketing of pharmaceuticals to kids and told COPPA does the job already. If you're interested in doing something about the issue, send in comments to the Federal Trade Commission about proposed changes to rules under COPPA, the Children's Online Privacy Protection Act. The changes don't necessarily help. Trade policy and drug prices. Pharmaceutical pricing issues are front-and-center in the debate over the Korea-US free trade agreement under consideration by Congress, and the Trans-Pacific Partnership Agreement still under negotiation. Read about why these agreements need to be fixed. There is plenty of concern about trade agreements in other countries, and the potential to limit access to generic AIDS drugs and other medications. Don't forget to check out summer legislative conferences of interest including NCOIL, which will focus on trade issues, including impacts on pharmaceutical policy, later this week on July 14 during its Annual Meeting in Newport, and NCSL which has meetings on trade August 8 and on health policy throughout its Legislative Summit in San Antonio. Sincerely, Sharon Treat |